Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Rodger

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Thrombosis Research|February 7, 2018
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolismMarc Rodger, Nicole Langlois, Saskia Middeldorp, et al.
Thrombosis Research|March 21, 2017
N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE studyKim Ma, Susan R Kahn, Andrew M Hirsch, et al.
Thrombosis and Haemostasis|October 25, 2013
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysisMarco P Donadini, Walter Ageno, Emilia Antonucci, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Research Involvement and Engagement|December 6, 2025
Patient engagement and shared decision-making in trial recruitment intervention studies: a systematic reviewTamara L Morgan, Natasha Hudek, Kelly Carroll, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
The New England Journal of Medicine|May 16, 2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgeryDean A Fergusson, Paul C Hébert, C David Mazer, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2025
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort studyVicky Mai, Emily S L Martens, Marc Righini, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Thrombosis Research|February 7, 2018
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolismMarc Rodger, Nicole Langlois, Saskia Middeldorp, et al.
Thrombosis Research|March 21, 2017
N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE studyKim Ma, Susan R Kahn, Andrew M Hirsch, et al.
Thrombosis and Haemostasis|October 25, 2013
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysisMarco P Donadini, Walter Ageno, Emilia Antonucci, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Research Involvement and Engagement|December 6, 2025
Patient engagement and shared decision-making in trial recruitment intervention studies: a systematic reviewTamara L Morgan, Natasha Hudek, Kelly Carroll, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
The New England Journal of Medicine|May 16, 2008
A comparison of aprotinin and lysine analogues in high-risk cardiac surgeryDean A Fergusson, Paul C Hébert, C David Mazer, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2025
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort studyVicky Mai, Emily S L Martens, Marc Righini, et al.
Pageof 10